Table 6.
The average amount of vitamins intake in the supplementation and placebo groups
| Variables | Measurement stage | Supplementation group (n=45) | Placebo group (n=45) | P-value |
|---|---|---|---|---|
| VitB1 (mg) | At baseline | 0.98±0.87 | 0.78±0.77 | >0.05 |
| 4th week | 1.6±0.82 | 0.69±0.82 | ||
| 6th week | 0.98±0.7 | 0.78±0.7 | ||
| VitB3 (mg) | At baseline | 17±9 | 19±9 | >0.05 |
| 4th week | 17±9.3 | 19±9.3 | ||
| 6th week | 17±8.7 | 18±8.7 | ||
| Folate (μg) | At baseline | 59±54 | 70±54 | .0.05 |
| 4th week | 64±67 | 74±71 | ||
| 6th week | 64±78 | 70±73 | ||
| VitC (mg) | At baseline | 54±78 | 74±82 | >0.05 |
| 4th week | 84±73 | 91±56 | ||
| 6th week | 87±68 | 93±48 | ||
| VitB2 (μg) | At baseline | 1.6±0.32 | 1.4±0.32 | <0.05a, <0.05b |
| 4th week | 1.6±0.34 | 1.6±0.33 | ||
| 6th week | 1.6±0.32 | 1.1±0.32 | ||
| VitB6 (mg) | At baseline | 1.3±0.32 | 1.4±0.32 | <0.05a, <0.05b |
| 4th week | 1.6±0.55 | 1.6±0.17 | ||
| 6th week | 1.6±0.12 | 1.5±0.32 | ||
| VitB12 (mg) | At baseline | 4.3±0.7 | 5.7±0.4 | >0.05 |
| 4th week | 3.5±0.8 | 4.8±0.8 | ||
| 6th week | 3.5±0.2 | 4.4±0.5 | ||
| VitD (μg) | At baseline | 32±0.7 | 37±0.4 | >0.05 |
| 4th week | 38±0.8 | 38±0.8 | ||
| 6th week | 39±0.8 | 38±0.5 | ||
| VitA (μg) | At baseline | 459.43±52.01 | 460.39±62.01 | >0.05 |
| 4th week | 476±61.2 | 458±50.2 | ||
| 6th week | 476±61.71 | 457±61.71 | ||
| VitE (mg) | At baseline | 14.43±12.01 | 16.39±12.01 | <0.05a, <0.05b |
| 4th week | 14.5±11.2 | 15.6±10.2 | ||
| 6th week | 15.67±10.71 | 15.77±11.71 | ||
| Beta-carotene (μg) | At baseline | 45.43±12.01 | 47.39±12.01 | >0.05 |
| 4th week | 47.5±11.2 | 48.6±10.2 | ||
| 6th week | 42.67±10.71 | 45.77±11.71 |
Notes:
a
Independent-sample t-test significant difference in the 6th week between groups.
b
Repeated measures ANOVA significant difference in the supplementation and placebo groups. Data are presented as mean ± SD.
Abbreviations: ANOVA, analysis of variance; SD, standard deviation.